TY  - JOUR
AU  - Sanchez-Correa, Beatriz
AU  - Bergua, Juan M
AU  - Pera, Alejandra
AU  - Campos, Carmen
AU  - Arcos, Maria Jose
AU  - Bañas, Helena
AU  - Duran, Esther
AU  - Solana, Rafael
AU  - Tarazona, Raquel
PY  - 2017
DO  - 10.3389/fimmu.2017.00931
SN  - 1664-3224
UR  - http://hdl.handle.net/10668/11522
T2  - Frontiers in immunology
AB  - Despite recent progress in the therapeutic approach of malignant hemopathies, their prognoses remain frequently poor. Immunotherapy could open a new window of great interest in this setting. Natural killer (NK) cells constitute an important area of...
LA  - en
PB  - Frontiers Research Foundation
KW  - NKp30
KW  - Acute myeloid leukemia
KW  - Dendritic cells
KW  - Interleukin-15
KW  - Natural killer cell
KW  - Natural killer cell degranulation
KW  - Interleukin-15
KW  - Up-regulation
KW  - Leukemia, myeloid, acute
KW  - Immunotherapy
KW  - Hematologic neoplasms
KW  - Myelodysplastic syndromes
KW  - Prognosis
KW  - Dendritic cells
TI  - In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients.
TY  - research article
VL  - 8
ER  -